olivLaw · US equity research
CitroTech Inc. CITR
Chemicals & Allied Products · SIC 2800 · Vertical: Chemicals & Allied Products (SIC 2800)
CitroTech Inc. (CITR) is a specialty chemical company developing environmentally sustainable fire inhibitors for wildland fire, home protection and wood products markets. The company reported revenue of 2.381407 million USD in 2025, up from 0.808372 million USD in 2024, yet still posted large net losses, which makes its financing position central in 2026.
At the close of 04 Nov 2026, CitroTech Inc. (CITR) stock was 2.43 USD (+3.85% on the day), with market capitalisation 54.8 m USD, beta 0.86, 52-week range 2.34–10.09 USD. Latest reported quarter (Q2 2026): revenue of 280.7 k USD (−59.2% YoY), net income of -3.9 m USD, diluted EPS -0.18 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 32.4
- weak (30–45)
- Bollinger (20, 2)
- 2.33 – 3.03
- in the lower half of the band · %B 0.14 · band width 26.1%
- SMA 50 / 200
- 3.83 / 6.17
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.36 / -0.42
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −14.7% | −1.1% | −13.6 pp | — |
| 3 months | −58.2% | −0.5% | −57.7 pp | — |
| 6 months | −66.0% | +4.4% | −70.4 pp | — |
| Year to date | −69.9% | +12.3% | −82.2 pp | — |
| 1 year | unavailable | +13.5% | unavailable | +2.1% |
| 3 years | unavailable | +76.4% | unavailable | −36.5% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 107.0 k | 69.6 k | 969.4 k | 687.6 k | 288.2 k | 436.2 k | 344.9 k | 280.7 k |
| Cost of revenue | 139.2 k | 317.3 k | 617.3 k | 371.4 k | 575.6 k | 346.7 k | 225.6 k | 271.6 k |
| Research & development | — | — | 8.0 k | 41.3 k | — | — | 81.5 k | 197.1 k |
| Operating income | -561.4 k | -1.2 m | -3.5 m | -3.0 m | -4.2 m | -5.8 m | -4.4 m | -3.5 m |
| Depreciation & amortisation | 63.6 k | 74.4 k | 74.5 k | 77.1 k | 90.1 k | 87.6 k | 125.7 k | 123.9 k |
| Interest expense | 93.9 k | 163.0 k | 410.8 k | 552.1 k | 360.2 k | 187.8 k | 164.8 k | 3.6 k |
| Pre-tax income | -655.2 k | -1.8 m | -10.9 m | -11.9 m | -7.9 m | -6.1 m | -6.2 m | -3.9 m |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -655.2 k | -1.8 m | -10.9 m | -11.9 m | -7.9 m | -6.1 m | -6.2 m | -3.9 m |
| Diluted EPS | -0.11 | -0.30 ≈ | -1.37 | -1.14 | -0.59 | -0.34 ≈ | -0.33 | -0.18 |
| Operating cash flow | -551.3 k ≈ | -617.8 k | -713.9 k | -1.2 m ≈ | -1.5 m ≈ | -2.5 m | -2.1 m | -1.8 m ≈ |
| Capex | 0 ≈ | 0 | 27.0 k | 140.8 k ≈ | 53.9 k ≈ | -27.7 k | 10.7 k | 0 ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | unavailable | unavailable | 0 | 62.7 k | 520.6 k | 808.4 k | 2.4 m |
| Revenue YoY | unavailable | unavailable | unavailable | unavailable | +730.0% | +55.3% | +194.6% |
| Net income | 0 | -109.4 k | -95.0 k | -2.9 m | -10.1 m | -6.9 m | -36.8 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| Diluted EPS | unavailable | 0.00 | 0.00 | 0.00 | -0.10 | -0.82 | -2.96 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| net % | unavailable | unavailable | unavailable | -4,635.3% | -1,940.3% | -851.3% | -1,546.9% |
| Free cash flow | unavailable | unavailable | -24.2 k | -713.8 k | -1.2 m | -1.9 m | -6.1 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 6.3 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 11.3 m USD
- Total assets
- 14.2 m USD
- Debt / equity
- unavailable
- Current ratio
- 3.42x
- ROE
- -505.4%
- ROA
- -374.7%
- FCF margin
- -254.6%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 62.7 k | 520.6 k | 808.4 k | 2.4 m | SEC (XBRL)· 30 Mar 2026verified |
| Cost of revenue | 0 | 18.6 k | 56.3 k | 182.7 k | 655.5 k | 1.9 m | SEC (XBRL)· 30 Mar 2026verified |
| Gross profit | 0 | 20.3 k | 60.8 k | 387.1 k | 152.9 k ≈ | 530.7 k ≈ | SEC (XBRL)· 30 Mar 2026derived |
| Research & development | — | — | — | 0 | 14.0 k | 198.5 k | SEC (XBRL)· 30 Mar 2026verified |
| Operating income | -109.4 k | -37.9 k | -2.9 m | -10.1 m | -5.3 m | -16.5 m | SEC (XBRL)· 30 Mar 2026verified |
| Depreciation & amortisation | — | 9.7 k | 15.9 k | 248.5 k | 264.7 k | 329.3 k | SEC (XBRL)· 30 Mar 2026verified |
| EBITDA | — | -28.2 k ≈ | -2.9 m ≈ | -9.8 m ≈ | -5.0 m ≈ | -16.2 m ≈ | SEC (XBRL)· 30 Mar 2026derived |
| Interest expense | 0 | 1.5 k | 255 | 4.3 k | 257.8 k | 1.5 m | SEC (XBRL)· 30 Mar 2026verified |
| Pre-tax income | -109.4 k | -45.0 k | -2.9 m | -10.1 m | -6.9 m | -36.8 m | SEC (XBRL)· 30 Mar 2026verified |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | SEC (XBRL)· 30 Mar 2026verified |
| Net income | -109.4 k | -95.0 k | -2.9 m | -10.1 m | -6.9 m | -36.8 m | SEC (XBRL)· 30 Mar 2026verified |
| Diluted EPS | 0.00 | 0.00 | 0.00 | -0.10 | -0.82 | -2.96 | SEC (XBRL)· 30 Mar 2026verified |
| Weighted average diluted shares | — | 22.9 m | 75.3 m | 96.7 m | 8.4 m | 12.4 m | SEC (XBRL)· 30 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue; Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 0 | 5.5 k | 55.4 k | 549.8 k | 775.1 k | 6.3 m | SEC (XBRL)· 30 Mar 2026verified |
| Receivables | — | — | 0 | 427.4 k | 317.5 k | 209.0 k | SEC (XBRL)· 30 Mar 2026verified |
| Inventories | — | 0 | 114.6 k | 230.2 k | 324.7 k | 620.8 k | SEC (XBRL)· 30 Mar 2026verified |
| Current assets | 0 | 5.5 k | 170.3 k | 1.2 m | 1.6 m | 7.4 m | SEC (XBRL)· 30 Mar 2026verified |
| Property, plant & equipment, net | 0 | 291.4 k | 4.5 k | 7.3 k | 111.4 k | 630.3 k | SEC (XBRL)· 30 Mar 2026verified |
| Intangibles (excl. goodwill) | — | 0 | 4.2 m | 3.9 m | 3.7 m | 5.3 m | SEC (XBRL)· 30 Mar 2026verified |
| Total assets | 0 | 330.2 k | 4.4 m | 5.3 m | 5.5 m | 14.2 m | SEC (XBRL)· 30 Mar 2026verified |
| Accounts payable | 0 | 10.7 k | 87.4 k | 54.6 k | 48.2 k | 316.3 k | SEC (XBRL)· 30 Mar 2026verified |
| Short-term debt | — | — | — | 0 | 96.8 k | — | SEC (XBRL)· 31 Mar 2025verified |
| Long-term debt | — | — | — | — | 0 | — | SEC (XBRL)· 12 Nov 2025verified |
| Current liabilities | 9.4 k | 383.1 k | 1.1 m | 1.6 m | 2.2 m | 2.2 m | SEC (XBRL)· 30 Mar 2026verified |
| Total liabilities | 9.4 k | 383.1 k | 1.1 m | 1.7 m | 2.2 m | 2.9 m | SEC (XBRL)· 30 Mar 2026verified |
| Equity | -9.4 k † | -52.9 k † | 3.3 m † | 3.6 m † | 3.3 m † | 11.3 m † | SEC (XBRL)· 30 Mar 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 0 | -24.2 k | -708.5 k | -1.2 m | -1.9 m | -5.9 m | SEC (XBRL)· 30 Mar 2026verified |
| Capex | — | 0 | 5.4 k | 4.0 k | 0 | 194.0 k | SEC (XBRL)· 30 Mar 2026verified |
| Free cash flow | — | -24.2 k ≈ | -713.8 k ≈ | -1.2 m ≈ | -1.9 m ≈ | -6.1 m ≈ | SEC (XBRL)· 30 Mar 2026derived |
| Investing cash flow | 0 | -287.1 k | -5.3 k | -4.0 k | 0 | -294.0 k | SEC (XBRL)· 30 Mar 2026verified |
| Financing cash flow | 0 | 316.8 k | 763.8 k | 1.7 m | 2.2 m | 11.7 m | SEC (XBRL)· 30 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- indicators available: 5 of at least 6
- score weight coverage: 33.3% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 54.8 m USD
Key indicators
Coverage and freshness
Score by group
33% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -1,788.4% | 14 (vs peers) | 19% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 236.1% | 100 (on a fixed band) | 25% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -25.1x | 0 (on a fixed band) | 19% |
| Current ratio · Balance sheet | 8.8x | 100 (on a fixed band) | 13% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -14.3% | 0 (on a fixed band) | 25% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth· partial100/100 · 1/2 factors with a value
- Quality· partial14/100 · 1/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
CitroTech Inc. (CITR). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 2.4 m USD in 2025; YoY growth 194.6%; net margin -1,788.4%; ROE -431.0%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (indicators available: 5 of at least 6; score weight coverage: 33.3% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Revenue CAGR 3Y: 236.1%
- Current ratio: 8.8x
What contradicts it
- Net margin: -1,788.4%
- Interest coverage: -25.1x
- FCF yield: -14.3%
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Chemicals & Allied Products (SIC 2800) · same industry (4-digit SIC) · compared with 14 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| SOLSSolstice Advanced Materials Inc. | 9.1 bn | 28.3 | 13.6% | 7.8% | +3.1% | +21% / unavailable |
| BCPCBalchem Corporation | 5.8 bn | 34.4 | 13.0% | 15.4% | +8.8% | +17% / +46% |
| PRMPerimeter Solutions, Inc. | 4.6 bn | — | -30.9% | -44.9% | +16.4% | +1% / +575% |
| NGVTIngevity Corporation | 2.5 bn | 50.1 | 64.4% | 4.7% | −2.7% | +41% / +90% |
| CCThe Chemours Company | 2.1 bn | — | -339.7% | -5.2% | +0.4% | +8% / −50% |
| OLNOlin Corporation | 2.1 bn | — | -12.2% | -3.3% | +3.7% | −14% / −62% |
| IOSPInnospec Inc. | 2.0 bn | 14.2 | 10.5% | 7.5% | −3.7% | +8% / −23% |
| HUNHuntsman Corporation | 1.7 bn | — | -11.8% | -5.8% | −5.8% | −5% / −60% |
| ECVTEcovyst Inc. | 1.1 bn | — | -9.6% | -7.1% | +20.9% | +8% / +5% |
| FMCFmc Corporation | 998.7 m | — | -226.7% | -151.2% | −18.3% | −55% / −88% |
| ACNTAscent Industries Co. | 124.0 m | — | -1.1% | -1.0% | −7.2% | −3% / +68% |
| CITRCitroTech Inc. | 54.8 m | — | -431.0% | -1,788.4% | +194.6% | unavailable / unavailable |
| LOOPLoop Industries, Inc. | 13.0 m | — | — | -2,154.3% | −95.3% | −77% / −92% |
| GUREGulf Resources, Inc. | 5.6 m | — | -32.4% | -134.4% | +231.8% | +3% / −80% |
| ADURAduro Clean Technologies Inc. | — | — | -133.8% | -5,253.1% | −31.5% | −26% / unavailable |
1- and 3-year price returns: for CITR from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
CitroTech Inc. (CITR) is a specialty chemical company developing environmentally sustainable fire inhibitors for wildland fire, home protection and wood products markets. The company reported revenue of 2.381407 million USD in 2025, up from 0.808372 million USD in 2024, yet still posted large net losses, which makes its financing position central in 2026.
SWOT
Strengths
- EPA Safer Choice recognition and UL GREENGUARD Gold certification that differentiate the product in the market.
- Broad patent portfolio protecting chemistry, application methods and defense systems.
- Rapid sales growth and better customer diversification in 2025.
Weaknesses
- Large net losses and accumulated deficit, with dependence on external financing.
- A small management team, several members of which do not work full time.
- Internal control weaknesses, including insufficient segregation of duties.
Opportunities
- Development of the HexiTech partnership for factory-applied Class A lumber.
- Turning the insurance pilot program into a commercial offering for CitroSafe systems.
- Expanding the certified partner network and municipal prevention programs.
Threats
- Competition from established players with much greater resources.
- Regulatory or testing-standard changes that could delay sales.
- Shareholder dilution from repeated need for capital.
Risks
- Funding needhigh
The company said existing resources may be sufficient only through fiscal 2026, and a lack of capital could force it to curtail or cease operations 1.
- Concentrated controlhigh
One principal stockholder controls most of the vote through preferred shares, which could limit the influence of other shareholders 1.
- Seasonal dependencemedium
Sales are sensitive to weather and the fire season, and an atypical year could affect results 1.
- Product liabilitymedium
Product liability insurance limits could prove insufficient in the event of major claims 1.
- Internal controls and key personnelmedium
The loss of key members could seriously affect operations, and the company has no key person insurance 1.
Investment thesis
What would need to be true (bull case)
- If fire seasons keep lengthening and insurance programs become operational, the company could benefit from rising demand for its products 12.
- EPA Safer Choice recognition and the HexiTech partnership could open access to large industrial lumber markets 12.
- Customer diversification, with far lower revenue share from the top five customers, could reduce concentration risk 1.
What would break the thesis
- Large losses and the need for more capital could lead to dilution or unfavorable financing terms 1.
- Concentrated control by one stockholder could limit protections for other investors 1.
- If pilot programs such as the insurance program do not turn into revenue, the company could remain dependent on seasonal sales 12.
What to watch
- Progress on financing and capital needs2027
- Results of the HexiTech joint ventureQ1 2027
- Status of pending patent applications and QPL testing2027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
CitroTech Inc. presents itself as a specialty chemical company focused on environmentally sustainable fire inhibitors for the wood products industry, home protection and wildland fire defense across the United States and Canada 1. Its flagship CitroTech product is described as the only fire inhibitor recognized by the EPA under the Safer Choice program, which the filing presents as its main competitive argument 1. The company had 14 full-time employees at year-end 2025 and relies on a patent portfolio held through its subsidiary Mighty Fire Breaker LLC 1.
Segments
Market context
The company cites a third-party forecast that the global fire-retardant market will reach 13.6 billion USD by 2034 1. The North American market is described as open to new non-toxic products, particularly in the United States and Canada 1.
Demand is supported by longer fire seasons, expansion of the wildland-urban interface and tougher compliance requirements 12. However demand is strongly weather-dependent, and sales are typically higher in the summer 1.
Trends
- Longer fire seasonstailwind
Longer and more severe fire seasons could increase demand for fire inhibitors and preventive treatments 12.
- Insurance market disruption for wildfiretailwind
Carrier withdrawal from high-risk zones could make CitroSafe systems more attractive if the broker program becomes operational 12.
- Building code and testing requirementsmixed
WUI codes and testing standards change often, which may require additional testing and added costs 1.
- Sustainability and non-toxic productsmixed
Pressure for eco-friendly products could favor a product with EPA Safer Choice recognition, but may also attract competition from large producers 1.
Competitive position
The company states it is not aware of offerings that combine fire inhibition performance with EPA Safer Choice recognition, but acknowledges that the market includes participants with longer histories, larger customer bases and significantly greater resources 1. Pressure-treated lumber remains in use and could bring competition from established players 1.
Competitors may adopt aggressive pricing and invest more in marketing and systems than CitroTech does, which could limit growth if the company fails to reinforce its patent and certification advantage 1.
- Traditional fire-retardant chemical producers
Described in the filing as using chemistries containing toxic metals, but with larger customer bases and resources; no specific ticker is identified.
- Pressure-treated lumber industry
Established players producing Class A lumber through pressure treatment; the source does not name them.
- Hexion Inc.
Partner in the HexiTech joint venture rather than a direct competitor; its role in the go-to-market strategy is noted in the filing 2.
- Fire safety industry participants
The filing mentions partial market overlap but gives no verified names or tickers.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Tribunalul București a deschis procedura generală de insolvență a AnimaWings; Banca Transilvania, ROMATSA și mai multe aeroporturi, printre creditori; CITR, Infinexa și Popescu & Asociații, desemnați administratori judiciari provizoriiFinancial Intelligence (RO) · 29 Oct 2026 · RO
- Anima Wings a intrat azi oficial în insolvenţă, la cererea proprie. Tribunalul Bucureşti a numit administrator judiciar consorţiul format din CITR, Infinexa Restructuring şi Popescu&Asociaţii Insolvency. Printre creditori, Banca Transilvania, ROMATSA şi aeroporturile din Bucureşti, Cluj şi Timişoara. Avocatul Anima, Piperea&AsociaţiiZiarul Financiar · 28 Oct 2026 · RO
- Ionuţ Daniel Coleaşă, CITR: „Avem o creştere a numărului de insolvenţe anul acesta de 12%, în primele 9 luni din 2026 versus 9 luni din 2025. Dacă facem un zoom in, în agricultură şi în sectorul construcţiilor este cea mai mare creştere. Anul acesta s-au văzut dificultăţile financiare din ultimii 3-4 ani de zile şi nu doar din 2026”Ziarul Financiar · 26 Oct 2026 · RO
- VIDEO Bani există și pentru companiile în dificultate, dar investitorii cer mai multă predictibilitate. Paul-Dieter Cîrlănaru, CEO CITR: Statul este implicat în unele dintre cele mai mari restructurări - Profit Financial.forumProfit.ro · 22 Oct 2026 · RO
- Paul-Dieter Cîrlănaru, CEO CITR, vine la Profit Financial.forumProfit.ro · 14 Oct 2026 · RO
- CITR: Șantierul Naval Mangalia a fost vândut către Rheinmetall pentru 138 de milioane de euroAgerpres · 09 Oct 2026 · RO
- Damen Shipyards Mangalia, vândut către Rheinmetall Real Estate România SRL pentru 138.034.320,47 milioane de euro, fără TVA (CITR)Financial Intelligence (RO) · 09 Oct 2026 · RO
- Presiunea insolvenţelor se mută spre companiile mari. CITR: Numărul firmelor cu active de peste 4 mil. euro intrate în procedură a crescut de peste două ori în primele nouă luni din 2026Ziarul Financiar · 08 Oct 2026 · RO
- CITR: Insolvențele cresc cu aproape 12% în primele nouă luni; numărul companiilor mari intrate în procedură s-a dublat; agricultură și Moldova, cele mai expuseFinancial Intelligence (RO) · 08 Oct 2026 · RO
- CITR: Insolvențele cresc cu aproape 12% în primele nouă luni; numărul companiilor mari intrate în procedură s-a dublat; agricultura și Moldova, cele mai expuseJuridice.ro · 08 Oct 2026 · RO
- CITR: Efectul opririi CNE Cernavodă se transmite la furnizorii de energie, urmaţi de consumatorii industriali şi furnizori. ”Fereastra de renegociere a contractelor de furnizare şi de discuţie cu finanţatorii este deschisă acum, înaintea ciclului contractual de iarnă”Ziarul Financiar · 08 Sept 2026 · RO
- CITR: Efectul opririi CNE Cernavodă se transmite pe trei verigi, iar prima care resimte presiunea este cea a furnizorilor de energieFinancial Intelligence (RO) · 08 Sept 2026 · RO
- CITR: Noua procedură de valorificare a Șantierului Naval Mangalia permite accelerarea procesului de vânzareFinancial Intelligence (RO) · 07 Sept 2026 · RO
- CITR, lichidator judiciar al Euroins România, a blocat în istanţă recunoaşterea pe teritoriul României a unei decizii de arbitraj din Bulgaria, care prevedea plata unei taxe de 12,7 mil.euro de către compania de asigurăriZiarul Financiar · 17 Aug 2026 · RO
- CITR obține două decizii importante în dosarul Euroins România: 12,7 milioane de euro rămân în patrimoniul companiei, iar hotărârea arbitrală de la Sofia nu este recunoscută în RomâniaJuridice.ro · 17 Aug 2026 · RO
- CITR: Insolvenţele din agricultură au crescut cu aproape 80% în S1/2026. Numărul companiilor cu active de peste 4 mil. euro intrate în insolvenţă a urcat de la una la 19Ziarul Financiar · 29 Jul 2026 · RO
- Zi critică la şantierul naval Damen Mangalia: Astăzi are loc a doua licitaţie, toţi cei 1.000 de angajaţi au fost concediaţi cu salarii compensatorii. Sindicatul spune că nimeni nu a depus garanţia. CITR şi ministrul Darău nu răspundZiarul Financiar · 29 Jul 2026 · RO
- Studiu CITR: Metalurgia românească se reconfigurează: companiile stabile rezistă şi cresc, 17% din firme ies din piaţă, iar afacerile scad cu 5,5 miliarde lei în 2023–2025Ziarul Financiar · 07 Jul 2026 · RO
- UPDATE – Nicio ofertă pentru Liberty Galaţi la preţul de 463 de milioane de euro, deşi existau cinci investitori interesaţi / Euro Insol – CITR: Interesul pentru Combinatul Siderurgic Galaţi rămâne activ; procesul de vanzare continuăMoney.ro · 19 Jun 2026 · RO
- Euro Insol CITR: Înscrierea litigiului din Cehia în Cartea funciară nu afectează planul de restructurare al Liberty GalațiEconomedia · 16 Jun 2026 · RO
SEC filings
- Current report22 Oct 2026Material agreement · Regulation FD disclosure · Financial statements and exhibits
- Current report14 Sept 2026Material agreement · Regulation FD disclosure · Financial statements and exhibits
- Quarterly report10 Aug 2026
- Current report17 Jun 2026Departure or appointment of officers
- Current report01 Jun 2026Material agreement · Item 3.02 · Financial statements and exhibits
- Quarterly report15 May 2026
- Current report21 Apr 2026Material agreement · Financial statements and exhibits
- Current report03 Apr 2026Material agreement · Departure or appointment of officers · Financial statements and exhibits
- Annual report30 Mar 2026
- Current report28 Jan 2026Amendments to articles or bylaws · Other events · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / CitroTech Inc. · 30 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / CitroTech Inc. · 10 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / CitroTech Inc. · 15 Aug 2006
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.